Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,307,942
+$459,981 QoQ
Shares Held
99,278
-5.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. IDYA ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in IDYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,307,942 | 99,278 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $2,847,961 | 104,666 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $785,916 | 37,389 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,463,159 | 89,326 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $4,597,524 | 178,892 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,619,070 | 145,804 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,528,625 | 100,502 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,941,514 | 44,246 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $874,485 | 24,578 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $333,796 | 12,372 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $265,483 | 19,336 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,016,357 | 55,936 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $266,724 | 17,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $149,647 | 10,844 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $225,030 | 20,110 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $557,890 | 23,740 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $432,544 | 30,896 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $832,740 | 66,301 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $227,487 | 16,009 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $51,092 | 12,401 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||